Jingjing Gao

ORCID: 0000-0002-0791-4951 · 1 paper in corpus

rct 2018

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial

Obstetrics and gynecology ·doi:10.1097/aog.0000000000002933

OBJECTIVE: To evaluate elagolix, an oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy, in premenopausal women with heavy menstrual bleeding (greater than 80 mL per month) associated with uterine leiomyo…